Cancer Profile, Longevity Profile Tests, Early Detection, Monitoring
In this video, Emil Schandl spends about 27 minutes speaking on "Cancer Profile, Longevity Profile Tests, Early Detection, Monitoring" at the 41st Annual Cancer Convention held on Labor Day weekend by the Cancer Control Society.
About Emil Schandl
EMIL SCHANDL, Ph.D. received a B.A. Degree from the University of California, Santa Barbara (Analytical Biology), M.S. from a San Diego State University, San Diego, California (Biochemistry and Enzymology) and a Ph.D. from the Institute of Molecular Biophysics, Florida State University, Tallahassee (Molecular Genetics). He pursued training in Nuclear Medicine and Clinical Laboratory Medicine at a Humana Hospital in Hollywood, Florida.
He is a Clinical Laboratory Director in the specialties of Clinical Chemistry, Hematology, Serology and Immunohematology in the states of Florida, New York, California and a number of others.
Dr. Schandl is a Fellow of the National Academy of Clinical Biochemistry, certified by the American Society of Clinical Pathologists, registered by the National Registry in Clinical Chemistry and past Consultant to the U.S. Environmental Protection Agency, Toxicology Department. He has been a Professional Staff member of two acute care hospitals in Hollywood, Florida. Dr. Schandl has published numerous articles in scientific refereed journals and has written news articles on cancer, multiple sclerosis, hyperactivity, anti-fluoridation of drinking water, etc.
Emil served on Florida Senator, Hon. Mackās U.S. Senatorial Cancer Advisory Committee for 10 years to advise on national cancer policies.
Since 1977, Dr. Schandl has been the Director of the Center for Metabolic Disorders, CA Laboratory and currently American Metabolic Laboratories, Metabolic Research, Inc. and Immuno Laboratories. He is the inventor/designer of the blood tests Cancer ProfileĀ©, (CA ProfileĀ©) for early detection and follow-up of malignancies and also of the Longevity ProfileĀ©, an expansion of the Cancer Profile. These blood test panels can foretell cancer, heart disease, bone loss and lack of longevity factors, years before a diagnosis can be made by any other methods.
Presently Dr. Schandl is working on the development of cancer specific antibodies and the applicability of stem cells in various diseased conditions.
He can be reached at the American Metabolic Laboratories in Hollywood, Florida by phone 954-929-4814 and e-mail [email protected]
Transcription
Good morning, everybody.
I was thinking this morning, how would I start my dog here? So I started with a prayer, thanking my creator for his love and mercy and provisions. Then I went to the washroom and I took a high KAWATANI again and want to get rid of all what there might be. So I am here clean, pure and good.
And then I was putting my suit on and I as my wife, I told my wife actually that, you know, I wore this suit on one of my first presentations in the late 70s to the biochemical society. And I'm asking her about what you think about that. She says, well. I think you are in pretty much the same good shape as you were in the 70s, and I think you had cheap soap.
So I slept with that.
With that introduction, the title of my talk is The Role of cancer profile. Longevity Profile. Time Eating kind is one telomerase in carcinogenesis and therapy so that, you know, I do better bolly consultations as a result of test results that we obtain in the clinical obituary in Hollywood, Florida, and also an intake from an individual age, weight, height, complaint's diagnosis, blood pressure. A number of things in this metabolic program is very powerful and we've been following this with blood tests and see quite a bit of success. I was somewhat surprised when I heard some speakers saying and talking about a good number of cancers. There are so many and many of them. And I was remembering Dr. Baird, if you remember, in 1982, I think it was when he published his so-called uniform Unity Theory of Cancer, where he proclaimed that cancer is all a one source, one disease of the truffle blast, which are embryonic cells. This these drawerful bless are totipotent cells, unlike stem cells, which means that they can become anything in embryogenesis or later on in life. You heard of stem cells? Of course, I heard several talks about that. The situation with stem cells is that and what's been established. You need to check this out for yourself. What I recall is that stem cells are resistant to chemo and radiation, all the surrounding tissue. And the person who is receiving those other therapies may undergo some trials and tribulations and deterioration. But the stem cells will say, no, we are going to get you. So that is still not quite clear as to what kind of stem cells someone should have. If you get it and you need to ask the doctor who is doing it, did they ever type the stem cells, whether so-called